These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2828441)

  • 1. Significance of resistance of herpes simplex virus to acyclovir.
    Crumpacker CS
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):190-5. PubMed ID: 2828441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase.
    Larder BA; Derse D; Cheng YC; Darby G
    J Biol Chem; 1983 Feb; 258(3):2027-33. PubMed ID: 6296119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
    Larder BA; Darby G
    Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A perspective on resistance to acyclovir in herpes simplex virus.
    Field HJ
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():129-35. PubMed ID: 6313592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?
    Sacks SL; Wanklin RJ; Reece DE; Hicks KA; Tyler KL; Coen DM
    Ann Intern Med; 1989 Dec; 111(11):893-9. PubMed ID: 2554768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acyclovir-resistant herpes simplex virus].
    Aukrust P
    Tidsskr Nor Laegeforen; 1990 Sep; 110(21):2770-3. PubMed ID: 2171155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biochemistry and mechanism of action of acyclovir.
    Elion GB
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():9-17. PubMed ID: 6313600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and biochemical characterization of clinical isolates of herpes simplex virus type 2 resistant to acyclovir.
    Oliver NM; Collins P; Van der Meer J; Van't Wout JW
    Antimicrob Agents Chemother; 1989 May; 33(5):635-40. PubMed ID: 2546486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.
    Collins P; Ellis MN
    J Med Virol; 1993; Suppl 1():58-66. PubMed ID: 8245894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance.
    Darby G; Field HJ; Salisbury SA
    Nature; 1981 Jan; 289(5793):81-3. PubMed ID: 6256650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities.
    Furman PA; Coen DM; St Clair MH; Schaffer PA
    J Virol; 1981 Dec; 40(3):936-41. PubMed ID: 6275127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir.
    Larder BA; Darby G
    Antimicrob Agents Chemother; 1986 May; 29(5):894-8. PubMed ID: 3015009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
    Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclovir resistance in herpes simplex virus type 1: biochemical and functional studies on the thymidine kinase of the highly resistant R100 strain.
    Palú G; Bevilacqua F; Biasolo MA; Parolin C; Tognon M; Romanelli MG; Meloni GA
    Virus Res; 1989 Aug; 13(4):303-18. PubMed ID: 2554611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.
    Field HJ; Larder BA; Darby G
    Am J Med; 1982 Jul; 73(1A):369-71. PubMed ID: 6285724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mechanisms of resistance to acyclovir in herpes simplex virus.
    Crumpacker CS; Schnipper LE; Chartrand P; Knopf KW
    Am J Med; 1982 Jul; 73(1A):361-8. PubMed ID: 6285723
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance of herpes simplex to acyclovir.
    Balfour HH
    Ann Intern Med; 1983 Mar; 98(3):404-6. PubMed ID: 6299155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.